92 related articles for article (PubMed ID: 4221944)
1. Cellular antibody in mice bearing Ehrlich cancer. II. Properties of lymphoid cells from sensitized animal.
Hara S
Acta Med Okayama (1952); 1965 Apr; 19(2):99-106. PubMed ID: 4221944
[No Abstract] [Full Text] [Related]
2. Cellular antibody in mice bearing Ehrlich cancer. I. A quantitative study on antitumor activity of cellular antibody in vitro.
Hara S
Acta Med Okayama (1952); 1965 Apr; 19(2):91-8. PubMed ID: 4221891
[No Abstract] [Full Text] [Related]
3. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
[No Abstract] [Full Text] [Related]
4. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
Loring M; Schlesinger M
Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
[No Abstract] [Full Text] [Related]
5. Action mechanism in vitro of sensitized regional lymph node cells on target cell. II. Difference in the biological effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11 cell).
Konaga E
Acta Med Okayama (1952); 1972 Aug; 26(3):99-117. PubMed ID: 4268713
[No Abstract] [Full Text] [Related]
6. Investigations on mononuclear cells of animals sensitized against homologous normal tissue transplants and tumor transplants.
Warnatz H
Arch Immunol Ther Exp (Warsz); 1966; 14(6):748-52. PubMed ID: 5334579
[No Abstract] [Full Text] [Related]
7. Action mechanism in vitro of sensitized regional lymph node cells on target cell. I. Anti-growth effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11).
Konaga E
Acta Med Okayama (1952); 1971 Aug; 25(4):269-85. PubMed ID: 4263561
[No Abstract] [Full Text] [Related]
8. Cellular antibody in mice bearing Ehrlich cancer. 3. Relationship of cellular antibody to serum antibody.
Hara S
Acta Med Okayama (1952); 1965 Dec; 19(6):279-86. PubMed ID: 4223615
[No Abstract] [Full Text] [Related]
9. Antitumor factors of draining lymph node cells of the mouse sensitized with ehrlich ascites tumor cells. I. Antitumor effect of subcellular factor.
Nakashima Y
Acta Med Okayama (1952); 1969 Apr; 23(2):95-104. PubMed ID: 4242310
[No Abstract] [Full Text] [Related]
10. [Studies on immune response of experimental tumors--observations on the immune response of lymph nodes of mice bearing implanted Ehrlich ascitic tumor or sarcoma 180 (author's transl)].
Chen QF; Zhou SL; Liu QR
Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):193-6. PubMed ID: 7227183
[No Abstract] [Full Text] [Related]
11. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
Dvorák R; Lindner J
Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
[No Abstract] [Full Text] [Related]
12. Immune reactions in Ehrlich ascites tumour-bearing mice.
Olinescu A; Babeş S; Piţur I
Arch Roum Pathol Exp Microbiol; 1980; 39(3):249-57. PubMed ID: 7018456
[No Abstract] [Full Text] [Related]
13. Studies on inhibitory effect of homologous spleen cells on Ehrlich ascites tumor and Yoshida sarcoma.
Soeda M
Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb; 26(11):1471-82. PubMed ID: 5231926
[No Abstract] [Full Text] [Related]
14. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
15. Tumor inhibition by means of sensitized regional lymph nodes.
Arlen M; Forte RA; Levowitz BS; Scherrer J; Hodenberg M
Surg Forum; 1969; 20():114-5. PubMed ID: 5383023
[No Abstract] [Full Text] [Related]
16. [Regulation of tumor cell growth by the tumor-bearing host (author's transl)].
Tanino T
Tanpakushitsu Kakusan Koso; 1973 Oct; 18(10):947-59. PubMed ID: 4588293
[No Abstract] [Full Text] [Related]
17. Immunological evidences for proliferation and migration of lymphocytes induced by administration of potent antitumor phosphomucolipid in tumor-bearing mice.
Mita A
Rev Eur Etud Clin Biol; 1972 Nov; 17(9):860-7. PubMed ID: 4569609
[No Abstract] [Full Text] [Related]
18. [Data concerning protective substances in immune tissues (short report)].
Glezer IM; Geĭtman IIa
Biull Eksp Biol Med; 1968; 66(7):92-3. PubMed ID: 5758105
[No Abstract] [Full Text] [Related]
19. A kinetic aspect of the antibody production against Ehrlich tumor cells in mice bearing Ehrlich solid tumor.
Kaneko Y; Nitta K; Umezawa H
Gan; 1975 Oct; 66(5):573-5. PubMed ID: 1220993
[TBL] [Abstract][Full Text] [Related]
20. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
Sheeja K; Kuttan G
Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
